The Association Between High CHA2DS2-VASc Scores and Short and Long-Term Mortality for Coronary Care Unit Patients

Long Cheng1, Sheng Kang2, Li Lin2

  • 1Department of Cardiovascular Medicine, Shanghai Pudong New Area Gongli Hospital, Shanghai, P.R. China.

Insights

A high CHA2DS2-VASc score is linked to increased mortality in coronary care unit (CCU) patients. This finding highlights the score's importance in predicting short-term and long-term survival for CCU admissions.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Public Health

Background:

  • The CHA2DS2-VASc score is recognized for its prognostic value in cardiovascular diseases.
  • Understanding its association with mortality in coronary care unit (CCU) patients is crucial for risk stratification.

Purpose of the Study:

  • To investigate the relationship between the CHA2DS2-VASc score and all-cause mortality in CCU patients.
  • To assess the score's predictive power for 30-day, in-hospital, 1-year, and 5-year mortality.

Main Methods:

  • Utilized the Medical Information Mart for Intensive Care (MIMIC) III database for CCU patient data.
  • Employed propensity score matching (PSM) to balance baseline characteristics between low (CHA2DS2-VASc score 0-3) and intermediate/high risk (score 4-9) groups.
  • Applied restricted cubic splines to analyze the association of various biomarkers with 30-day mortality post-PSM.

Main Results:

  • Patients with intermediate/high CHA2DS2-VASc scores exhibited significantly higher 30-day, 1-year, and 5-year mortality rates compared to low-risk patients.
  • Hazard ratios indicated increased mortality risk across all assessed time points for higher scores.
  • Nonlinear relationships were observed between 30-day mortality and specific biomarkers like platelets, hemoglobin, white blood cell count, glucose, potassium, and sodium.

Conclusions:

  • Elevated CHA2DS2-VASc scores independently predict increased 30-day, 1-year, and 5-year mortality in CCU patients.
  • The CHA2DS2-VASc score serves as a valuable prognostic tool for CCU populations.
  • Further research can explore the impact of specific biomarkers on mortality within different CHA2DS2-VASc score strata.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
112
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
28
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
25
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
50
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31